Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open- Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial - Andre, T; Vernerey, D; Mineur, L (J Clin Oncol, 2018)
et al.